Literature DB >> 19360403

Primary neuroendocrine tumor of the sacrum: case report and review of the literature.

Fanny Dujardin1, Pauline Beaussart, Anne de Muret, Philippe Rosset, Eric Waynberger, Denis Mulleman, Gonzague de Pinieux.   

Abstract

Primary carcinoid tumor (well-differentiated neuroendocrine tumor) of the bone involving the sacrum is extremely rare. We report the case of a 72-year-old man who presented with a 20-year history of intermittent low back pain and was found to have an intraosseous sacral mass on imaging. A needle biopsy revealed that this lesion was a well-differentiated neuroendocrine tumor. Workup did not show any primary tumor or other metastatic disease. There was no associated tailgut cyst or sacrococcygeal teratoma. The lesion was treated with radiation therapy because a surgical approach was rejected. The patient is free of metastatic disease after 28 years evolution of the lesion, retrospectively seen to be present on a conventional radiography performed in 1980. A review of the literature revealed 20 case reports of neuroendocrine tumors arising from the presacral region (with or without associated tailgut cyst or sacrococcygeal teratoma) and sometimes extending to the sacrum. One additional case was located within the neural canal and involved the sacrum, the presacral region, and the rectal wall. Our case is the only tumor arising primarily from the sacrum. The long evolution of this lesion without any other location makes metastatic disease very improbable and this case appears to be a unique example of primary intraosseous sacral carcinoid tumor.

Entities:  

Mesh:

Year:  2009        PMID: 19360403     DOI: 10.1007/s00256-009-0693-y

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  28 in total

1.  Carcinoid tumor in a presacral teratoma associated with an anterior sacral meningocele: case report and review of the literature.

Authors:  M S Fiandaca; W K Ross; G S Pearl; R A Bakay
Journal:  Neurosurgery       Date:  1988-03       Impact factor: 4.654

Review 2.  Retrorectal carcinoid tumor.

Authors:  T Gorski; I T Khubchandani; J J Stasik; R Riether
Journal:  South Med J       Date:  1999-04       Impact factor: 0.954

Review 3.  Tailgut cyst associated with a carcinoid tumor: case report and review of the literature.

Authors:  A Mathieu; R Chamlou; F Le Moine; C Maris; J Van de Stadt; I Salmon
Journal:  Histol Histopathol       Date:  2005-10       Impact factor: 2.303

4.  Carcinoid tumor of the coccyx: case report and review of the literature.

Authors:  E Krasin; A Nirkin; J Issakov; M Rabau; I Meller
Journal:  Spine (Phila Pa 1976)       Date:  2001-10-01       Impact factor: 3.468

5.  Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.

Authors:  P F Quaedvlieg; O Visser; C B Lamers; M L Janssen-Heijen; B G Taal
Journal:  Ann Oncol       Date:  2001-09       Impact factor: 32.976

Review 6.  Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case.

Authors:  T V Luong; S Salvagni; C Bordi
Journal:  Dig Liver Dis       Date:  2005-01-08       Impact factor: 4.088

Review 7.  Metastatic carcinoid tumors: a clinical review.

Authors:  Johanna M Zuetenhorst; Babs G Taal
Journal:  Oncologist       Date:  2005-02

8.  Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.

Authors:  J M Zuetenhorst; C A Hoefnageli; H Boot; R A Valdés Olmos; B G Taal
Journal:  Nucl Med Commun       Date:  2002-08       Impact factor: 1.690

Review 9.  Imaging of sacral tumours.

Authors:  S Gerber; L Ollivier; J Leclère; D Vanel; G Missenard; H Brisse; G de Pinieux; S Neuenschwander
Journal:  Skeletal Radiol       Date:  2007-11-23       Impact factor: 2.199

Review 10.  Anatomic and functional imaging of metastatic carcinoid tumors.

Authors:  Andrew F Scarsbrook; Arul Ganeshan; Jane Statham; Rajesh V Thakker; Andrew Weaver; Denis Talbot; Philip Boardman; Kevin M Bradley; Fergus V Gleeson; Rachel R Phillips
Journal:  Radiographics       Date:  2007 Mar-Apr       Impact factor: 5.333

View more
  7 in total

Review 1.  Ghrelin-producing well-differentiated neuroendocrine tumor (carcinoid) of tailgut cyst. Morphological, immunohistochemical, ultrastructural, and RT-PCR study of a case and review of the literature.

Authors:  Stefano La Rosa; Luigi Boni; Giovanna Finzi; Davide Vigetti; Nikolaos Papanikolaou; Silvia Maria Tenconi; Gianlorenzo Dionigi; Moira Clerici; Silvana Garancini; Carlo Capella
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

2.  [PSAP expression in a primary presacral neuroendocrine tumor. Potential for confusion with prostate cancer].

Authors:  T Menter; A Fischmann; K Glatz
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

3.  Primary carcinoid tumor of medulla spinalis: case report and review of the literature.

Authors:  Xian-feng Zhang; Yan Zhang; Xu Yan; Li Bie
Journal:  Eur J Med Res       Date:  2014-12-19       Impact factor: 2.175

4.  Primary neuroendocrine tumor in the presacral region: A case report.

Authors:  Rui Zhang; Yong Zhu; Xiao-Bo Huang; Chris Deng; Min Li; Guang-Shu Shen; Shu-Liang Huang; Shao-Hua Huangfu; Yan-Ni Liu; Chun-Gen Zhou; Ling Wang; Qi Zhang; Youping Deng; Bin Jiang
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

5.  Primary cervical spine carcinoid tumor in a woman with arm paresthesias and weakness: a case report.

Authors:  Mohan Narayanan; Daniel Serban; Gabriel C Tender
Journal:  J Med Case Rep       Date:  2013-08-23

6.  Primary Neuroendocrine Tumor of the Lumbar Spine: Rare Tumor Mimicking Nerve Sheath Tumor of the Spine.

Authors:  Sanjay Kumar; Vikas Maheshwari; Aishik Mukherjee; Deep Kumar Raman
Journal:  Asian J Neurosurg       Date:  2019 Jul-Sep

7.  Neuroendocrine tumor of thoracic spine: case report and literature review.

Authors:  Huiquan Gao; Yanzhen Wan; Hongxia Ma; Tao Huang; Wei Song
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.